Skip to main content
Thorax logoLink to Thorax
. 1971 Sep;26(5):551–554. doi: 10.1136/thx.26.5.551

Use of sodium cephalothin in the management of lung gangrene

B T Le Roux 1
PMCID: PMC472346  PMID: 5134056

Abstract

Thirty-one of 256 cases of chronic destructive pneumonia who were judged, by the severity of illness and haemoptysis, to have lung gangrene, were managed with intravenous sodium cephalothin. Five patients died, two in relation to emergency pneumonectomy. In comparison with results of management of this disease in previous, similar patients, the results are encouraging.

Full text

PDF
551

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BARBER M., WATERWORTH P. M. PENICILLINASE-RESISTANT PENICILLINS AND CEPHALOSPORINS. Br Med J. 1964 Aug 8;2(5405):344–349. doi: 10.1136/bmj.2.5405.344. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Kabins S. A., Cohen S. Cephaloridine therapy as related to renal function. Antimicrob Agents Chemother (Bethesda) 1965;5:922–932. [PubMed] [Google Scholar]
  3. Kunin C. M., Atuk N. Excretion of cephaloridine and cephalothin in patients with renal impairment. N Engl J Med. 1966 Mar 24;274(12):654–656. doi: 10.1056/NEJM196603242741205. [DOI] [PubMed] [Google Scholar]
  4. Merrill S. L., Davis A., Smolens B., Finegold S. M. Cephalothin in serious bacterial infection. Ann Intern Med. 1966 Jan;64(1):1–12. doi: 10.7326/0003-4819-64-1-1. [DOI] [PubMed] [Google Scholar]
  5. Rahal J. J., Jr, Meyers B. R., Weinstein L. Treatment of bacterial endocarditis with cephalothin. N Engl J Med. 1968 Dec 12;279(24):1305–1309. doi: 10.1056/NEJM196812122792403. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES